In SLE, serum type I IFN levels and interferon-stimulated gene (ISG) expression correlate with disease severity, supporting the hypothesis that proinflammatory IFNs contribute to both the onset and propagation of ILD. This evidence concerns the gene STING1 and systemic lupus erythematosus.